07 May 2021 – Nitong hapon, nakatanggap tayo ng magandang balita na inaprubahan na ng Food And Drug Administration o F-D-A ang Certificate of Product Registration o C-P-R ng Lloyd Laboratories para sa paggamit ng gamot na Ivermectin sa tao. Dahil dito, nagpapasalamat kami sa FDA sa pamumuno ni Director General Eric Domingo sa pakikinig.. read more
Statement of the Anti-Red Tape Authority on FDA’s Issuance of LTO to Ivermectin Compounder Dr. Allan Landrito
Following our insistent calls to expedite the processing of permit applications, the Anti-Red Tape Authority (ARTA) is pleased to learn that the Food and Drug Administration (FDA) has issued a License to Operate (LTO) for medicine trading to Dr. Allan Landrito, a vocal proponent of using Ivermectin to treat COVID-19. ARTA was informed about this.. read more
Statement of the Anti-Red Tape Authority on FDA’s Granting of Compassionate Special Permit to a Hospital for use of Ivermectin on Covid-19 patients
The Anti-Red Tape Authority (ARTA) welcomes the move of the Food and Drug Administration (FDA) for granting the application of a hospital for a Compassionate Special Permit to use Ivermectin on humans with COVID-19. With this, ARTA urges FDA to continue processing applications from other medical institutions seeking the same permit expeditiously while key agencies.. read more
ARTA to discuss with DOH, FDA the inclusion of Ivermectin in the COVID-19 treatment protocol for emergency use
30 March 2021 – The Anti-Red Tape Authority (ARTA) will discuss the possible inclusion of Ivermectin in the COVID-19 treatment protocol with the Department of Health (DOH) and the Food and Drug Administration (FDA) on its meeting with the said agencies tomorrow, Wednesday. This, after FDA Director General Eric Domingo explained in a meeting earlier.. read more